Transparency in the advertising of medicinal products and medical devices

The new rules aimed at safeguarding transparency in the advertising of medicinal products and medical devices or in connection with their promotion are stimulating or reviving the debate on the matter.

On February 5 of this year, Decree-Law No. 5/2017, of January 6, entered into force, which approved the general principles of advertising of medicines and medical devices, and in this framework amended Decree- Law no. 176/2006 of August 30, which establishes the legal framework for medicinal products for human use, as well as Decree-Law no. 145/2009, of June 17, which establishes the legal framework of medical devices and accessories.

One of the most recurring doubts on this subject is related to the entities considered beneficiaries for this purpose. Jane Kirkby, BAS’s attorney and partner, takes a closer look at this issue in an article that can be read here.

More in Communication